Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) and Repligen (NASDAQ:RGEN – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and earnings. Insider & Institutional Ownership 33.4% of Anavex Life […]